Deferred Tax Assets, Valuation Allowance of IMMUCELL CORP /DE/ from 30 Sep 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IMMUCELL CORP /DE/ quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2018 to 31 Dec 2024.
  • IMMUCELL CORP /DE/ Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $4,593,989, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,593,989 +$559,959 +14% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $4,034,030 +$1,325,276 +49% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $2,708,754 +$2,630,667 +3369% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $78,087 -$349,913 -82% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $428,000 -$1,109,354 -72% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $1,537,354 +$296,347 +24% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 $1,241,007 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $878,977 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.